DOCS
Doximity Inc
26.50$
-1.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.4% | +7.9% | -0.5% | +4.2% | +4.8% | +7.9% | -4.7% | +4.4% | -8.0% | -2.9% | -3.5% | |
| – | -2.5% | +8.6% | -0.5% | +5.4% | +5.7% | +7.5% | -5.0% | +5.6% | -9.0% | -5.0% | -3.2% | |
| – | +13.5% | -21.4% | +15.1% | +65.3% | -10.3% | +26.8% | -34.5% | +23.3% | -61.7% | +238.0% | +24.8% | |
| – | -2.7% | +7.4% | -1.6% | +7.3% | +4.9% | +8.4% | -8.2% | +4.4% | -16.3% | +1.8% | -8.1% | |
| – | +0.4% | +3.8% | +19.3% | +3.2% | +10.2% | -6.7% | +10.4% | -8.7% | +21.1% | -7.5% | +22.6% | |
| – | +98.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +25.1% | +0.0% | +0.0% | +0.0% | |
| – | -3.6% | -3.7% | -3.9% | -4.0% | -4.2% | -4.4% | -4.3% | +77.4% | -4.8% | -5.2% | -5.5% | |
| – | -11.7% | +30.8% | -10.2% | -1.6% | -10.4% | +28.8% | -1.6% | -9.7% | +10.0% | -2.7% | -2.9% | |
| – | -15.0% | +40.6% | -8.1% | -2.2% | -12.4% | +34.8% | +2.3% | -12.3% | +6.8% | +3.4% | -3.0% | |
| – | +9.0% | +1.9% | +1.9% | +1.5% | +1.5% | -2.0% | -1.9% | -2.1% | -2.1% | +1.5% | +1.5% | |
| – | +163.3% | +19.8% | -26.5% | +67.3% | -40.9% | -17.1% | +44.7% | +123.8% | +9.0% | -16.2% | +62.0% | |
| – | -0.8% | +4.3% | +1.4% | +5.2% | +7.3% | +5.0% | -5.3% | +6.8% | -10.6% | -2.9% | -3.7% | |
| – | -28.6% | +31.1% | -8.8% | +30.6% | +58.8% | +23.6% | -37.3% | +34.7% | -86.7% | -343.5% | – | |
| – | -4.1% | +0.3% | -0.9% | +0.6% | +0.9% | +0.4% | -0.9% | -0.2% | -0.8% | -2.1% | -2.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.